Sign in: Staff/Students
The Royal is the first NHS clinical research unit in England that meets the high standards required for early clinical trials
The Clinical Research Unit (CRU) at the Royal Liverpool University Hospital has become the first NHS facility in England to be granted Medicines and Healthcare products Regulatory Agency (MHRA) standard and supplementary Phase I Accreditation.
The accreditation means the Royal and the University of Liverpool has the first NHS clinical research unit in England that meets the high standards required for early clinical trials. This is where drugs or other treatments are tested on humans for the first time as part of tightly controlled research projects.
Latest drugs and technologies
MHRA Phase 1 Accreditation will allow the Trust to perform clinical trials in patients with some of the newest treatments under evaluation, to some of the most rigorous set of standards in the world. It will help provide patients with greater access to the very latest drugs and technologies and will bring economic benefits to the city of Liverpool as a centre for global healthcare research.
The MHRA Phase I Accreditation scheme was introduced to improve the safety of clinical research volunteers and assesses the capability of the clinical research unit based on facilities, procedures, training and experience of staff.
Dr Richard Fitzgerald, from the University’s Institute of Translational Medicine and Co-director of the Clinical Research Unit, said: “This will give local patients the opportunity to take part in clinical trials here at the Royal, using the very latest drugs and other treatments, as part of studies that will meet the highest standards within the safest environment.
Hub for world class research
“The Covance-Royal Liverpool University Hospital Clinical Research Unit together with its academic leads will be available for researchers across the Liverpool Health Partners for use in early phase clinical research.”
Royal chief executive Aidan Kehoe said, “This is excellent news for the Trust and our future plans to create the Liverpool BioCampus as a world leading centre in life sciences. Having MHRA Phase 1 Accreditation means we can build on Liverpool’s reputation as a hub for world class research which will help us improve healthcare for patients in the city and beyond.”
You must be logged in to post a comment.
All recent news
Digital innovation supporting jobs and business models in Covid-19 recovery
How to protect your property during the Christmas break
Prof Sir Munir Pirmohamed presents at Downing Street COVID-19 vaccine briefing
New consortium to accelerate development of Advanced Therapy Medicinal Products
8 steps to help keep your home safe during the pandemic
Today's News site front page 🗞️
Professor Sir Munir Pirmohamed presents at @10DowningStreet #vaccine briefing, detecting change in Arctic ecosystems and developing Advanced Therapy Medicinal Products
Find it all here ➡️ https://news.liverpool.ac.uk/
"The UK is now one step closer to providing a safe and effective #vaccine to help in the fight against #COVID19."
@livuniHLS Professor Sir Munir Pirmohamed speaking at Downing Street today. #LivUniCovid
Dr @parnell_daniel joins @FB_Collective podcast to discuss today's @DCMS hearing on Sport in the Community, and how it has been impacted by #COVID19
Listen here https://bit.ly/3lsS1JF